- Home
- AZN vs LIN Comparison
AZN vs LIN Comparison
Compare AZN & LIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZN
- LIN
- Stock Information
- Founded
- AZN 1992
- LIN 1879
- Country
- AZN United Kingdom
- LIN United Kingdom
- Employees
- AZN N/A
- LIN N/A
- Industry
- AZN Biotechnology: Pharmaceutical Preparations
- LIN Major Chemicals
- Sector
- AZN Health Care
- LIN Industrials
- Exchange
- AZN Nasdaq
- LIN Nasdaq
- Market Cap
- AZN 223.3B
- LIN 212.4B
- IPO Year
- AZN 1993
- LIN N/A
- Fundamental
- Price
- AZN $74.22
- LIN $458.00
- Analyst Decision
- AZN Strong Buy
- LIN Buy
- Analyst Count
- AZN 7
- LIN 12
- Target Price
- AZN $89.75
- LIN $500.50
- AVG Volume (30 Days)
- AZN 5.3M
- LIN 2.1M
- Earning Date
- AZN 02-06-2025
- LIN 02-06-2025
- Dividend Yield
- AZN 2.05%
- LIN 1.21%
- EPS Growth
- AZN 18.11
- LIN 8.18
- EPS
- AZN 4.50
- LIN 13.62
- Revenue
- AZN $54,073,000,000.00
- LIN $33,005,000,000.00
- Revenue This Year
- AZN $8.02
- LIN $6.37
- Revenue Next Year
- AZN $5.78
- LIN $5.99
- P/E Ratio
- AZN $32.62
- LIN $33.65
- Revenue Growth
- AZN 18.03
- LIN 0.46
- 52 Week Low
- AZN $62.75
- LIN $410.69
- 52 Week High
- AZN $87.68
- LIN $487.49
- Technical
- Relative Strength Index (RSI)
- AZN 64.25
- LIN 57.82
- Support Level
- AZN $73.58
- LIN $450.05
- Resistance Level
- AZN $74.74
- LIN $466.03
- Average True Range (ATR)
- AZN 1.16
- LIN 7.40
- MACD
- AZN 0.13
- LIN -0.08
- Stochastic Oscillator
- AZN 81.25
- LIN 68.60
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its sales.
About LIN Linde plc
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $33 billion in revenue in 2023.